DR. MENG ZHAO M.D. NPI 1083848337

NPI Details

DR. Meng Zhao, M.D. is a hematology and oncology internal medicine in Everett, WA with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Meng Zhao, M.D. NPI is 1083848337. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1717 13TH ST
EVERETT, WA
ZIP 98201-621
Phone: (425) 297-5560
Fax: (425) 297-5561

The NPI 1083848337 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Magnesium level (HCPCS:83735)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Phosphate level (HCPCS:84100)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Ferritin (blood protein) level (HCPCS:82728)
• Ct scan of chest with contrast (HCPCS:71260)
• Iron level (HCPCS:83540)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Unclassified drugs (HCPCS:J3490)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Uric acid level, blood (HCPCS:84550)
• Folic acid level, serum (HCPCS:82746)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)

The enumeration date for this NPI number is 5/14/2009 and was last updated on 7/31/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: